Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

A phase II/III clinical trial investigating the treatment of insomnia with a bilayer tablet formulation of adipiplon has been suspended

    • 15 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Neurogen Corporation.Neurogen Announces Suspension of Insomnia Study with Adipiplon. Media Release: 14 Jul 2008. Available from: URL: http://www.neurogen.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    A phase II/III clinical trial investigating the treatment of insomnia with a bilayer tablet formulation of adipiplon has been suspended. React. Wkly. 1212, 2 (2008). https://doi.org/10.2165/00128415-200812120-00003

    Download citation

    Keywords

    • Public Health
    • Clinical Trial
    • Control Release
    • Additional Investigation
    • Tablet Formulation